focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Trackwise Designs wins deal; Cake Box names CFO

Fri, 21st Oct 2022 21:29

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

ThinkSmart Ltd - Perth, Australia-based digital payments platform - Says the Federal Court of Australia approved orders for the company to convene a meeting of shareholders to vote on its acquisition by Tuscan Equity Pty Ltd. Expects the scheme meeting to take place through a computershare virtual meeting platform on November 16.

----------

Trackwise Designs PLC - Tewkesbury, Gloucestershire-based products using printed circuit technology - Enters a new agreement for a fixed quantity of flexible printed circuit boards which are due to be delivered through to July 2023 to its unnamed UK EV OEM customer. The new commercial order provides for a GBP4.0 million advanced payment in 2022.

----------

Cake Box Holdings PLC - Wembley, London-based egg-free cream cake seller - Appoints Michael Botha as chief financial officer. He has worked in senior finance and commercial role for the last 20 years.

----------

Globalworth Real Estate Investments Ltd - Investor in real estate in Central and Eastern Europe, with particular focus on Poland and Romania - Says Chief Executive Officer Dimitris Raptis has decided to step down as of December 31. Notes that he will continue to support Globalworth in an advisory role allowing time for a handover period. He joined in 2013 as deputy CEO & Chief Investment Officer and became CEO in 2020.

----------

Corero Network Securities PLC - Amersham, Buckinghamshire-based distributed denial of service cyber defence solutions - Expands its distributed denial of service protection partnership with Juniper Networks, across Juniper's PTX and MX series routers. The extensions prevent DDoS attack traffic and include new enhanced protections against DDoS "carpet bombing".

----------

Trident Royalties PLC - London-based mining royalty and streaming company - Notes Equinox Gold's updated feasibility study for its Los Filos mine complex in Mexico. Explains that the feasibility study contemplates the construction of a carbon-in-leach processing plant beginning in the half of 2023. It outlines peak gold production averaging 360,000 ounces per year to 2030 from 2025, including production in excess of 400,000 ounces in 2025. By comparison, Equinox's latest guidance for 2022 production at Los Filos is 155,000 to 170,000 ounces. Holds an offtake agreement for 50% of all refined gold production up to a cap of 1.1 million ounces from Los Filos. "Equinox continues to deliver on its growth plans with the release of this updated feasibility study, which highlights the tremendous potential at Los Filos. The potential expansion at Los Filos underscores the organic growth within Trident's gold offtakes portfolio," CEO Adam Davidson comments.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Says the required majorities of scheme shareholders voted to approve its acquisition by Neurocrine at a court meeting and general meeting.

----------

Secure Property Development & Investment PLC - London-headquartered commercial property investor focused on southeastern Europe - Chief Executive Officer Lambros Anagnostopoulos buys 1.9 million shares at GBP0.0575 each.

----------

IOG PLC - North Sea-focused gas and infrastructure operator - Chief Executive Officer Rupert Newall purchases 600,000 shares at 9.31 pence per ordinary share.

----------

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
2 Dec 2019 13:19

Diurnal submits application for 'Alkindi Sprinkle' to US FDA

(Sharecast News) - Specialty pharmaceutical company Diurnal Group has submitted a 'New Drug Application' (NDA) to the US Food and Drug Administration (FDA), for the regulatory approval of 'Alkindi Sprinkle', or hydrocortisone granules in capsules for opening, as a replacement therapy of adrenal insufficiency in infants, children and adolescents in the US, it announced on Monday.

Read more
21 Nov 2019 11:36

Diurnal Primary Focus Remains On Progressing Flagship Products

Diurnal Primary Focus Remains On Progressing Flagship Products

Read more
20 Nov 2019 11:36

Diurnal To Explore Further Tests As Testosterone Treatment Does Well

Diurnal To Explore Further Tests As Testosterone Treatment Does Well

Read more
24 Sep 2019 11:21

Diurnal Loss Narrows On Research Expenses And Alkindi Launch

Diurnal Loss Narrows On Research Expenses And Alkindi Launch

Read more
14 Jun 2019 14:26

Diurnal Shareholders Approve Placing, Open Offer Worth GBP6 Million (ALLISS)

(Alliance News) - Pharmaceutical firm Diurnal Group PLC's shareholders on Friday approved its GBP5.9 million fundraise completed earlier in the day.Diurnal, which focuses on patients or

Read more
28 May 2019 13:32

Diurnal Group launches placing and open offer to fund drug development

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced a conditional placing of new ordinary shares in the company and the launch of an open offer on Tuesday, in order to raise funds to progress the development and commercialisation of its products.

Read more
28 May 2019 10:49

Diurnal Raises GBP5 Million Via Placing; Plans GBP1 Million Open Offer (ALLISS)

LONDON (Alliance News) - Diurnal Group PLC said Tuesday it has raised around GBP5.4 million via a 20.6 million share placing priced at 26 pence per share and announced an open offer to raise up to

Read more
10 May 2019 09:36

Polar Capital Global Healthcare Lags Behind Benchmark In First Half

LONDON (Alliance News) - Polar Capital Global Healthcare Trust PLC said on Friday it lagged against its benchmark for the first half of its financial year, as the healthcare trust underperformed a

Read more
24 Apr 2019 15:50

Diurnal gets orphan drug designation for Alkindi in Australia

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Wednesday that its 'Alkindi' product - hydrocortisone granules in capsules for opening - had been granted orphan drug designation in Australia by the Therapeutic Goods Administration, for the indication 'replacement therapy of adrenal insufficiency (AI) in infants, children and adolescents from birth to 18 years old'.

Read more
24 Apr 2019 10:44

Diurnal Gets Orphan Drug Designation For Alkindi In Australia

LONDON (Alliance News) - Diurnal Group PLC on Wednesday said its adrenal insufficiency drug Alkindi has been granted a second patent and orphan drug designation in Australia.Shares in were

Read more
28 Mar 2019 08:35

Diurnal soars after securing Nordic distribution deal

(Sharecast News) - Diurnal's shares leapt on Thursday despite a widened interim loss as the company landed a marketing and distribution deal for its Alkindi treatment in Scandinavia.

Read more
21 Mar 2019 16:11

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 22 March Sanne GroupFull Year ResultsSmiths GroupHalf Year BootFull Year

Read more
20 Mar 2019 10:33

Diurnal Group upbeat following FDA meeting over 'Alkindi'

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Wednesday that, following a "positive" meeting with the US Food and Drug Administration (FDA), it intended to submit a new drug application (NDA) for 'Alkindi' (hydrocortisone granules in capsules for opening) in the fourth quarter of 2019 as previously planned, with final acceptance of the filing by the FDA expected in 2020.

Read more
25 Feb 2019 10:39

Diurnal expecting Israel launch of 'Alkindi' next year

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Monday that its marketing and distribution partner, Medison Pharma has successfully submitted a market authorisation application (MAA) for its 'Alkindi' (hydrocortisone granules in capsules for opening) product to the Ministry of Health in Israel.

Read more
10 Jan 2019 12:35

Diurnal Granted US Patent But Unsure Why Share Price Has Tripled

LONDON (Alliance News) - Diurnal Group PLC said on Thursday that, aside from the granting of a patent, it is unsure as to why its share price has tripled.Shares were 188% higher on Thursday

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.